Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
10/2013
10/17/2013WO2013152418A1 System and method for multiphasic release of growth factors
10/17/2013WO2013123432A3 Histidyl-trna synthetases for treating autoimmune and inflammatory diseases
10/17/2013WO2013112595A3 Methods and compositions for gene editing of a pathogen
10/17/2013WO2013042093A8 The use of the antibiotic bacitracin in the hydrolytic degradation of rna
10/17/2013WO2012118323A9 Fusion protein comprising albumin and a retinol-binding protein
10/17/2013WO2012116402A9 Binder powders
10/17/2013US20130276158 Methods and compositions for rna interference
10/17/2013US20130274704 Augmented cognitive training
10/17/2013US20130274689 Method for Reducing or Preventing Transplant Rejection in the Eye and Intraocular Implants for Use Therefor
10/17/2013US20130274314 Mitochondrial targeted rna expression system and use thereof
10/17/2013US20130274293 Pharmaceutical composition for treating and/or preventing a pathology associated with an obsessional behavior or with obesity
10/17/2013US20130274208 Small Peptides And Methods For Treatment Of Chronic Inflammatory Bowel Disease
10/17/2013US20130274207 Uses of Natriuretic Peptide Constructs
10/17/2013US20130274203 Anti-ssx-2 t cell receptors and related materials and methods of use
10/17/2013US20130274202 Peptides for Treating Cancer
10/17/2013US20130274198 Treating muc1-expressing cancers with combination therapies
10/17/2013US20130274196 Method for treatment of inflammatory disease and disorder
10/17/2013US20130274194 Factor VIII-Fc Chimeric and Hybrid Polypeptides, and Methods of Use Thereof
10/17/2013US20130274192 Microparticles containing physiologically active peptide, method for preparing the same, and pharmaceutical composition comprising the same
10/17/2013US20130274191 Methods and compositions for therapeutic modulation of aldosterone levels in heart disease
10/17/2013US20130274190 Biomaterial for wound healing and preparation thereof
10/17/2013US20130274186 Neurturin molecules
10/17/2013US20130274184 Er stress relievers in beta cell protection
10/17/2013US20130274183 Apparatus and method for automatically supplying insulin based on amount of exercise
10/17/2013US20130274181 Obesity-related genes and their proteins and uses thereof
10/17/2013US20130274180 Pharmaceutical Compositions
10/17/2013US20130274179 Viral polymerase inhibitors
10/17/2013US20130274178 Active Cores of Peptide Triazole HIV-1 Entry Inhibitors
10/17/2013US20130274175 Treatment of disease associated with the use of antibiotics
10/17/2013US20130274174 Therapeutic combination of daptomycin and protein synthesis inhibitor antibiotic, and methods of use
10/17/2013US20130274171 Trefoil factors (tff) for the treatment of chronic pulmonary diseases
10/17/2013US20130274141 METHODS AND KITS FOR SYNTHESIS OF siRNA EXPRESSION CASSETTES
10/17/2013US20130273651 Differentiated cells suitable for human therapy
10/17/2013US20130273169 Stable Solid Formulation of GC-C Receptor Agonist Polypeptide Suitable for Oral Administration
10/17/2013US20130273145 Compositions, the preparation and use thereof
10/17/2013US20130273143 Methods of improving cardiac function and attenuating and/or preventing cardiac remodeling with hsp20
10/17/2013US20130273136 Sustained drug delivery system
10/17/2013US20130273116 Anti-fouling composition comprising an aerogel
10/17/2013US20130273112 Consensus antigen constructs and vaccines made therefrom, and methods of using the same to treat malaria
10/17/2013US20130273084 Use of a dna expression construct
10/17/2013US20130273081 Vaccination against pcskk 9 for lowering cholesterol
10/17/2013US20130273075 Compounds and Method for Modulating Inflammatory Reactions
10/17/2013US20130273065 Therapeutic Compositions For Treatment Of Inflammation Of Ocular And Adnexal Tissues
10/17/2013US20130273057 Methods and compositions for the treatment and diagnosis of vascular inflammatory disorders or endothelial cell disorders
10/17/2013US20130273039 Combination therapies for b-cell lymphomas comprising administration of anti-cd20 antibody
10/17/2013US20130273028 Plasminogen and plasmin variants
10/17/2013US20130273026 Composition and method for modulating inflammatory molecules with amylase
10/17/2013US20130273022 Compositions of engineered human arginases and methods for treating cancer
10/17/2013US20130273020 Antifungal composition
10/17/2013US20130273018 Recombinant human cln2 protein and methods of its production and use
10/17/2013US20130273017 Methods and products for tissue repair
10/17/2013US20130273009 Methods to mobilize progenitor/stem cells
10/17/2013US20130273005 Methods for treating hcv
10/17/2013US20130273003 Therapies for Treating Hepatitis C Virus Infection
10/17/2013US20130273002 Multivalent breast cancer vaccine
10/17/2013US20130273000 Methods for treating viral infection using il-28 and il-29
10/17/2013US20130272999 Epidermal Growth Factor Composition, A Process Therefor and Its Application
10/17/2013US20130272998 Polynucleotide constructs, pharmaceutical compositions and methods for targeted downregulations of angiogenesis and anticancer therapy
10/17/2013US20130272997 Synthetic mechanical hemostatic composition, method of making and use thereof
10/17/2013US20130272964 Molecules with extended half-lives, compositions and uses thereof
10/17/2013CA2862290A1 Il-12 for radiation protection and radiation-induced toxicity mitigation
10/16/2013EP2650303A1 Methods and compositions for the treatment of heart failure and other disorders
10/16/2013EP2650302A1 Method for removing endotoxin from proteins
10/16/2013EP2650013A1 Inhibitors of Receptor for Advanced Glycation-End products (RAGE) for use in treating and/or preventing inflammation- and/or damage-induced cancer
10/16/2013EP2650012A1 Treatment of metastatic stage prostate cancer with degarelix
10/16/2013EP2650011A1 Method of treatment or prophylaxis
10/16/2013EP2650010A1 Method of treatment or prophylaxis
10/16/2013EP2650009A2 Screening methods using G-protein coupled receptors and related compositions
10/16/2013EP2650008A1 Use of cell-permeable peptide inhibitors of the JNK signal transduction pathway for the treatment of various cardiovascular diseases
10/16/2013EP2650007A1 Use of cell-permeable peptide inhibitors of the JNK signal transduction pathway for the treatment of various cardiovascular diseases
10/16/2013EP2650006A1 Analogues of exendin-4 and exendin-3
10/16/2013EP2650003A1 Degradable clostridial toxins
10/16/2013EP2649988A1 Sustained release of antiinfective aminoglycosides
10/16/2013EP2649095A2 Mimetic peptides derived from collagen type iv and their use for treating angiogenesis- and lymphangiogenesis- dependent diseases
10/16/2013EP2649091A1 Immune restricted peptides with increased efficacy
10/16/2013EP2648761A1 Cancer gene therapy using nucleic acids encoding us28 and g-protein
10/16/2013EP2648755A1 A stable ready-to-use cetrorelix injection
10/16/2013EP2648743A2 Agents for increased resistance against oxidative stress conditions
10/16/2013EP2648735A2 Granzyme b inhibitor compositions, methods and uses for promoting wound healing
10/16/2013EP2648734A1 Methods of metabolic targeting cancer cells using che mo- and immunotherapy for treating cancer
10/16/2013CN103352042A cDNA encoding recombinant Newcastle disease virus, virus rescued by cDNA, and application of cDNA in malignant tumor treatment
10/16/2013CN103351430A Fish nuclear factor 45 and application thereof
10/16/2013CN103351425A Disheveled pdz modulators
10/16/2013CN103349781A Modified chimeric polypeptides with improved pharmacokinetic properties
10/16/2013CN103349779A Healthcare soft capsule containing elements, vitamins and vegetable polyketide synthase and used for controlling cardiovascular and cerebrovascular diseases
10/16/2013CN103349778A Application of CC chemotactic factor of turbot
10/16/2013CN103349777A Crig polypeptide used for prevention and treatment of related disorder of alexin
10/16/2013CN103349776A Edaravone injection solution and preparation method thereof
10/16/2013CN103349775A Method for preparing hypoglycemic agent or hypoglycemic food with natural biological active proteins of rice
10/16/2013CN102935223B Application of polypeptide GC25 in preparing anti-infective drug
10/16/2013CN102875660B Virus induced protein Mig1 and application thereof
10/16/2013CN102813910B Medicine composition used for controlling poultry airsacculitis, and preparation method thereof
10/16/2013CN102690335B Polypeptide for effectively inhibiting activity of influenza virus polymerase
10/16/2013CN102675416B Beta-carboline derivatives, and preparation method and application thereof
10/16/2013CN102617722B Ancylostoma caninum anticoagulant peptide, preparation and application thereof
10/16/2013CN102559689B Prawn complement 1q binding protein and application thereof
10/16/2013CN102451471B Polyethyleneglycol-staphylokinase conjugate as well as preparing method and application thereof
10/16/2013CN102309765B Long-acting anticoagulant polypeptide including immunoglobulin Fc segments as carriers and preparation method of same
10/16/2013CN102276727B IL-17RC-hFc fusion protein and application thereof
10/16/2013CN102133396B Vaccine injection and preparation method thereof
1 ... 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 ... 3163